Viatris Reaffirms FY22 Revenue Outlook, Declares Dividend - Update
(RTTNews) - While reporting financial results for the third quarter on Monday, healthcare company Viatris Inc. (VTRS) reaffirmed its total revenue guidance for the full-year 2022 to solid operating momentum despite foreign exchange headwinds and absorbing inflation impact to date.
For fiscal 2022, the company continues to project total revenue between $16.2 billion and $16.7 billion. On average, 11 analysts polled by Thomson Reuters expect the company to report revenues of $16.00 billion for the year.
The company also said its Board of Directors declared a quarterly dividend of $0.12 for each issued and outstanding share of the company's common stock, payable on December 16, 2022, to shareholders of record at the close of business on November 23, 2022.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Viatris Announces US Commercial Launch Of RYZUMVl 0.75%
Viatris Guides FY24 In Line With Estimates - Update
Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend - Update
Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend - Update
Viatris To Acquire Oyster Point And Famy Life Sciences To Create Ophthalmology Franchise
U.S. District Court Rules In Favor Of Merck In Patent Infringement Suit Against Viatris
Viatris Trims FY22 Revenue Outlook, Declares Dividend - Update
